Molecule Name |
DB08965
|
DrugBank Groups |
Approved
|
Cluster No |
1035
|
Smiles |
O=C1(OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(OC(C(N(C1C(C)C)C)=O)C(C)C)=O)C(C)C)C)C(C)C)C(C)C)C)C(C)C)
|
Download |
mol2, pdbqt
|
TPSA |
139,83
|
Non-H Atoms |
45
|
Non-C/H Atoms |
12
|
Metal-Atoms |
0
|
Electronegative Atoms |
12
|
Stereo Centers |
6
|
Rotatable Bonds |
6
|
Rings Closures |
1
|
Small Rings |
0
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
30
|
Symmetric atoms |
6
|
cLogS |
-3,302
|
MW |
639,828
|
cLogP |
2,9163
|
HBA |
12
|
HBD |
0
|
Ro5 violations |
2
|
Druglikeness |
3,981
|
DrugScore |
0,499744418235826
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-1,003
|
Caco-2 Permeability 2 |
0,8986
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
2,0546
|
Tetrahymena Pyriformis Toxicity |
Low TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
-0,5179
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6681
|
Carcinogenicity (Three-class) |
Non-required
|